Candesartan N1-Ethyl Impurity
Product Description
CAT No.
ALN-C011036
CAS No.
1246817-38-8
Mol. F.
C26H24N6O3
Mol. Wt.
468.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 2-Ethoxy-1-[[2′-(1-ethyl-1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ;
Smiles : O=C(O)C1=CC=CC(N=C2OCC)=C1N2CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5CC
Inchi : InChI=1S/C43H34N6O3/c1-51-41(50)37-23-14-24-38-39(37)48(42(44-38)52-2)29-30-25-27-31(28-26-30)35-21-12-13-22-36(35)40-45-47-49(46-40)43(32-15-6-3-7-16-32,33-17-8-4-9-18-33)34-19-10-5-11-20-34/h3-28H,29H2,1-2H3
Synonym : N1-Ethyl Candesartan (Acid) ;
Technical Data
Reference
Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR
Bhanu Ramana,u2217, Brajesh A. Sharmaa,b, Ganesh Mahale b, Dharmendra Singhb, Ashok KumarnJournal of Pharmaceutical and Biomedical Analysis 56 (2011) 256u2013263
Synergistic suppression of tumor angiogenesis by codelivering of VEGF targeted siRNA and candesartan mediated by functionalized carbon nanovectors
Xuefang Ding, Yujie Su, Cheng Wang, Fangrong Zhang, Kerong Chen, Yu Wang, Min Li, and Wei Wang – ACS Appl. Mater. Interfaces 2017, 9, 28, 23353–23369
Identification, Isolation, and Characterization of Five Potential Degradation Impurities in Candesartan Cilexetil Tablets
Arivozhi Mohan1,&, S. Shanmugavel1 , Ajay Goyal1 , B. R. Venkataraman2 , D. Saravanan – Chromatographia volume 69, pages1211–1220(2009)
RFQ